---
title: "XORTX Therapeutics Inc. GAAP EPS of -$1.05"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296650983.md"
description: "XORTX Therapeutics Inc. GAAP EPS of -$1.05"
datetime: "2026-08-21T20:36:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296650983.md)
  - [en](https://longbridge.com/en/news/296650983.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296650983.md)
generator: "portal-rs"
---

# XORTX Therapeutics Inc. GAAP EPS of -$1.05


### Related Stocks

- [XRTX.US](https://longbridge.com/en/quote/XRTX.US.md)

## Related News & Research

- [XORTX starts GMP manufacturing for XORLO to support XRX-OXY-102 gout trial](https://longbridge.com/en/news/298638662.md)
- [Tsakos Energy Navigation GAAP EPS of $4.40, revenue of $298.41M beats by $69.5M](https://longbridge.com/en/news/298605008.md)
- [InMed Pharmaceuticals GAAP EPS of -$3.12](https://longbridge.com/en/news/298502732.md)
- [CEA Industries GAAP EPS of -$0.22](https://longbridge.com/en/news/298765617.md)
- [Clearmind Medicine Inc. GAAP EPS of -$0.57](https://longbridge.com/en/news/298641285.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**